Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

The neoplastically transformed (CD30hi) Marek's disease lymphoma cell phenotype most closely resembles T-regulatory cells.

Shack LA, Buza JJ, Burgess SC.

Cancer Immunol Immunother. 2008 Aug;57(8):1253-62. doi: 10.1007/s00262-008-0460-2. Epub 2008 Feb 7.

PMID:
18256827
3.

Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.

Kumar S, Kunec D, Buza JJ, Chiang HI, Zhou H, Subramaniam S, Pendarvis K, Cheng HH, Burgess SC.

BMC Syst Biol. 2012 Sep 14;6:123. doi: 10.1186/1752-0509-6-123.

5.

Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30).

Burgess SC, Young JR, Baaten BJ, Hunt L, Ross LN, Parcells MS, Kumar PM, Tregaskes CA, Lee LF, Davison TF.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13879-84. Epub 2004 Sep 8.

7.

Reduced incidence of Marek's disease gross lymphomas in T-cell-depleted chickens.

Sharma JM, Nazerian K, Witter RL.

J Natl Cancer Inst. 1977 Mar;58(3):689-92.

PMID:
190413
8.

Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity.

Kumar S, Buza JJ, Burgess SC.

Cancer Microenviron. 2009 Dec;2(1):23-31. doi: 10.1007/s12307-008-0018-z. Epub 2009 Mar 18.

9.

Hypomethylation upregulates the expression of CD30 in lymphoma induced by Marek's disease virus.

Zhang W, Qu L, Xu G, Lian L, Zheng J, Yang N.

Poult Sci. 2012 Jul;91(7):1610-8. doi: 10.3382/ps.2011-02086.

PMID:
22700506
10.

Detection of the meq gene in the T cell subsets from chickens infected with Marek's disease virus serotype 1.

Chang KS, Ohashi K, Lee SI, Takagi M, Onum M.

Jpn J Vet Res. 2005 Aug;53(1-2):3-11.

PMID:
16190317
11.

Transcriptional profiling of Marek's disease virus genes during cytolytic and latent infection.

Heidari M, Huebner M, Kireev D, Silva RF.

Virus Genes. 2008 Apr;36(2):383-92. doi: 10.1007/s11262-008-0203-7. Epub 2008 Feb 12.

PMID:
18266100
12.
13.

In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.

Ajithdoss DK, Reddy SM, Suchodolski PF, Lee LF, Kung HJ, Lupiani B.

Virus Res. 2009 Jun;142(1-2):57-67. doi: 10.1016/j.virusres.2009.01.008. Epub 2009 Feb 2.

PMID:
19189855
14.

Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis.

Shkreli M, Dambrine G, Soubieux D, Kut E, Rasschaert D.

J Virol. 2007 May;81(9):4848-57. Epub 2007 Feb 21.

15.

Transcriptional analysis of host responses to Marek's disease virus infection in genetically resistant and susceptible chickens.

Sarson AJ, Parvizi P, Lepp D, Quinton M, Sharif S.

Anim Genet. 2008 Jun;39(3):232-40. doi: 10.1111/j.1365-2052.2008.01710.x. Epub 2008 Mar 26.

PMID:
18371127
18.

Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.

Baaten BJ, Butter C, Davison TF.

Vet Immunol Immunopathol. 2004 Aug;100(3-4):165-77. Review.

PMID:
15207454
19.

CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.

Onaindia A, Martínez N, Montes-Moreno S, Almaraz C, Rodríguez-Pinilla SM, Cereceda L, Revert JB, Ortega C, Tardio A, González L, García S, Camacho FI, González-Vela C, Piris MA.

Am J Surg Pathol. 2016 Mar;40(3):378-85. doi: 10.1097/PAS.0000000000000571.

PMID:
26574847
20.

Using integrative genomics to elucidate genetic resistance to Marek's disease in chickens.

Cheng H, Niikura M, Kim T, Mao W, MacLea KS, Hunt H, Dodgson J, Burnside J, Morgan R, Ouyang M, Lamont S, Dekkers J, Fulton J, Soller M, Muir W.

Dev Biol (Basel). 2008;132:365-72.

PMID:
18817328

Supplemental Content

Support Center